养胃颗粒联合铋剂四联疗法治疗Hp 感染慢性非萎缩性胃炎脾胃气虚证临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R573.3

基金项目:


Clinical Study on Yangwei Granules Combined with Bismuth Quadruple Therapy for Chronic Non-Atrophic Gastritis Caused by Hp Infection with Spleen-Stomach Qi Deficiency Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察养胃颗粒联合铋剂四联疗法治疗幽门螺杆菌(Hp) 感染慢性非萎缩性胃炎脾胃气虚证 的临床疗效。方法:选取106例Hp感染慢性非萎缩性胃炎患者,按随机数字表法分为对照组和观察组各53例。 对照组予铋剂四联疗法,观察组在对照组基础上采取养胃颗粒治疗。2组连续治疗2周。比较2组临床疗效、 胃肠道症状评分、Hp根除率、脾胃气虚证症状评分以及血清肿瘤坏死因子(TNF) -α、白细胞介素(IL) -2、 IL-32水平。结果:2周疗程后,观察组总有效率为94.34%,高于对照组79.25%(P<0.05)。2周疗程结束后, 观察组Hp 根除率为92.45%,高于对照组75.47% (P<0.05)。治疗1 周、2 周后,2 组胃肠道症状分级量 表(GSRS) 评分较治疗前降低(P<0.05);且观察组GSRS 评分低于同时间点对照组(P<0.05)。治疗后, 2组脾胃气虚证症状评分较治疗前降低(P<0.05);且观察组脾胃气虚证症状评分低于对照组(P<0.05)。治 疗后,2组血清TNF-α、IL-32水平较治疗前降低,IL-2水平较治疗前升高(P<0.05);且观察组血清TNF-α、 IL-32水平低于对照组,IL-2水平高于对照组(P<0.05)。结论:养胃颗粒联合铋剂四联疗法治疗Hp感染慢性 非萎缩性胃炎脾胃气虚证的疗效明显,能改善患者胃肠症状与中医证候,提高Hp根除率,抑制炎症反应。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Yangwei Granules combined with bismuth quadruple therapy for chronic non-atrophic gastritis caused by helicobacter pylori (Hp) infection with spleenstomach qi deficiency syndrome. Methods: A total of 106 cases of patients with chronic non-atrophic gastritis caused by Hp infection were selected and divided into the control group and the observation group according to the random number table method,with 53 cases in each group. The control group was treated with bismuth quadruple therapy,and the observation group was additionally treated with Yangwei Granules based on the treatment of the control group. Both groups were continuously treated for two weeks. Clinical effects, gastrointestinal symptom scores, Hp eradication rates, symptom scores of the spleen and stomach qi deficiency syndrome, as well as levels of serum tumor necrosis factor (TNF) - α, interleukin (IL) -2, and IL-32 were compared between the two groups. Results: After two weeks of treatment courses, the total effective rate was 94.34% in the observation group, which was higher than that of 79.25% in the control group (P<0.05). After two weeks of treatment courses,the Hp eradication rate was 92.45% in the observation group, which was higher than that of 75.47% in the control group (P<0.05). After one and two weeks of treatment,the scores of the Gastrointestinal Symptom Rating Scale (GSRS) in the two groups were decreased when compared with those before treatment (P<0.05),and GSRS scores in the observation group were lower than those in the control group at the same time points (P<0.05). After treatment, symptom scores of the spleen-stomach qi deficiency syndrome in the two groups were decreased when compared with those before treatment (P<0.05), and symptom scores of the spleenstomach qi deficiency syndrome in the observation group were lower than those in the control group (P< 0.05). After treatment, levels of TNF- α and IL-32 in serum in the two groups were declined when compared with those before treatment,and IL-2 levels were increased (P<0.05);the levels of TNF-α and IL-32 in the observation group were lower than those in the control group, and IL-2 level in the observation group was higher than that in the control group (P<0.05). Conclusion: Yangwei Granules combined with bismuth quadruple therapy has a significant curative effect in the treatment of chronic nonatrophic gastritis caused by Hp infection with spleen-stomach qi deficiency syndrome,which can improve patients' gastrointestinal symptoms and traditional Chinese medicine syndromes, increase Hp eradication rates,and inhibit inflammatory response.

    参考文献
    相似文献
    引证文献
引用本文

韩芳,陈达伟,杨建巧.养胃颗粒联合铋剂四联疗法治疗Hp 感染慢性非萎缩性胃炎脾胃气虚证临床研究[J].新中医,2024,56(17):39-43

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-09-11
  • 出版日期:
文章二维码